Bluebird bio lays off 25% of workforce as gene therapy pioneer ...
WEB11 hours ago · Bluebird has repeatedly faced challenges as the entire gene therapy field has charted a rocky commercial path. Back in 2022, the company reduced its workforce by 30% and backed out of the European ...
Bluebird bio to cut 25% of workforce as part of restructuring
WEB7 hours ago · bluebird bio Inc. Follow. Sept 24 (Reuters) - Gene therapy maker bluebird bio (BLUE.O) said on Tuesday it would cut 25% of its workforce as part of a restructuring program for cost reduction. Keep ...
Bluebird Bio is laying off 25% of its workers to cut costs
WEB1 hour ago · Ruby Wallau for STAT. By Stella Tannenbaum — The Boston Globe. Sept. 24, 2024. Gene therapy company Bluebird Bio on Tuesday announced a 25% reduction of its workforce as part of a restructuring ...
Bluebird Bio To Reduce Approx. 25% Of Its Workforce - Quick Facts
WEB7 hours ago · Sep. 24, 2024, 07:11 AM. (RTTNews) - bluebird bio (BLUE) announced it is implementing a restructuring intended to optimize cost structure and enable quarterly cash flow break-even in the second ...
Bluebird bio to Cut 25% of Workforce in Restructuring
WEB7 hours ago · Bluebird bio is shedding about a quarter of its workforce as part of a restructuring plan aimed at reducing its cash operating expenses by around 20% and enabling quarterly cash flow break-even in ...
bluebird bio Initiates Restructuring Intended to Optimize Cost ...
WEB7 hours ago · SOMERVILLE, Mass., September 24, 2024--Following a comprehensive review of its operations, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is implementing a restructuring ...
Gene Therapy-Focused Bluebird Bio Restructures, Cuts Is …
WEB2 hours ago · On Tuesday, Bluebird bio, Inc. (NASDAQ:BLUE) announced it is implementing a restructuring intended to optimize its cost structure and enable quarterly cash flow break-even in the second half of 2025.
bluebird bio Initiates Restructuring Intended to Optimize Cost ...
WEBActions intended to reduce cash operating expenses by approximately 20%. Management team to host conference call today, September 24 at 8:00 am ET SOMERVILLE, Mass.--(BUSINESS WIRE)--Sep. 24, 2024-- Following a comprehensive review of its operations, bluebird bio, Inc. (Nasdaq: BLUE) today announced that the Company is implementing a restructuring intended to optimize the Company’s cost ...
press releases - bluebird bio, Inc.
WEBMay 29, 2024 · SOMERVILLE, Mass. --(BUSINESS WIRE)--Sep. 13, 2024-- bluebird bio, Inc. (Nasdaq: BLUE) today announced that it has completed the restatement of its consolidated financial statements for the year ended December 31, 2022 , and for each of the first three quarters of 2022 and 2023.
bluebird bio Reports First Quarter 2024 Results and Highlights ...
WEBSOMERVILLE, Mass., May 09, 2024 -- (BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today reported first quarter results and business highlights for the...